<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079089/" ref="ordinalpos=4274&amp;ncbi_uid=6315567&amp;link_uid=PMC4079089" image-link="/pmc/articles/PMC4079089/figure/F2/" class="imagepopup">Figure 2.  From: Growth arrest <span class="highlight" style="background-color:">signaling</span> of the Raf/MEK/ERK <span class="highlight" style="background-color:">pathway</span> in cancer. </a></div><br /><div class="p4l_captionBody">Two different thresholds of Raf/MEK/ERK activity determine cell fate to proliferation or growth arrest. In this model, not only too low but also too high Raf/MEK/ERK activity restricts cell proliferation. Different cell types may maintain different extent of pathway activity between these thresholds, displaying heterogeneous sensitivity to pathway activity.</div></div>